Switching Between LC-ESI-MS/MS and EMIT Methods for Routine TDM of Valproic Acid in Pediatric Patients With Epilepsy: What Clinicians and Researchers Need to Know

Background: Valproic acid (VPA) is a widely used antiseizure medication and its dosing needs to be tailored individually through therapeutic drug monitoring (TDM) to avoid or prevent toxicity. Currently, immune-enzymatic assays such as Enzyme Multiplied Immunoassay Technique (EMIT), and Liquid Chrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Ying, Long, Jia-Yi, Shen, Meng-Yuan, Dong, Na, Guo, Hong-Li, Hu, Ya-Hui, Lu, Xiao-Peng, Ding, Xuan-Sheng, Chen, Feng, Qiu, Jin-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650496/
https://www.ncbi.nlm.nih.gov/pubmed/34887756
http://dx.doi.org/10.3389/fphar.2021.750744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650496/
https://www.ncbi.nlm.nih.gov/pubmed/34887756
http://dx.doi.org/10.3389/fphar.2021.750744

Ejemplares similares